|
Dendritic Cell Vaccine Clinical Trials
2 actively recruiting trials across 1 location
Also known as: DCs
Pipeline
Phase 1: 2
Top Sponsors
- National Health Research Institutes, Taiwan1
- H. Lee Moffitt Cancer Center and Research Institute1
Indications
- Cancer2
- Refractory Tumor1
- Leptomeningeal Disease1
- Triple Negative Breast Cancer1
- HER2-positive Breast Cancer1
Other1 trial
Tampa, Florida1 trial
A First in Human Dose Escalation of Dendritic Cell Vaccine (DCV)
Moffitt Cancer Center
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.